BLS Pharmaceuticals Limited Share Price
Stocks
BLS
AU0000477796
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Australian S.E.
07:10:15 07/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 1.100 AUD | -3.51% |
|
+3.77% | +161.90% |
| 09-02 | BLS Pharmaceuticals Limited, 2026 Earnings Call, Sep 02, 2026 | |
| 08-31 | BLS Pharmaceuticals Limited Provides Earnings Guidance for the Fiscal Year 2027 | CI |
| Market Cap | 263M 189M 163M 153M 140M 262M 17.87B 1.81B 703M 9.17B 711M 695M 29.53B | P/E 2025 |
17.8x | P/E 2026 | 13.9x |
|---|---|---|---|---|---|
| Enterprise Value | 258M 186M 160M 150M 137M 257M 17.54B 1.78B 690M 9B 698M 682M 28.99B | EV / Sales 2025 |
2.82x | EV / Sales 2026 | 2.82x |
| Free-Float |
45.27% | Yield 2025 * |
-
| Yield 2026 | - |
Australian S.E.AUD
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| BLS | Delayed | |
Boerse Muenchen
| PR80 | Real-time | |
|
Deutsche Boerse AG
| PR80 | Delayed |
Last Transcript : BLS Pharmaceuticals Limited
| 1 day | -3.51% | ||
| 1 week | +3.77% | ||
| Current month | +3.77% | ||
| 1 month | +20.88% | ||
| 3 months | +19.57% | ||
| 6 months | +103.70% | ||
| Current year | +161.90% |
| 1 week | 1.06 |  | 1.2 |
| 1 month | 0.87 | | 1.2 |
| Current year | 0.36 | | 1.2 |
| 1 year | 0.33 | | 1.2 |
| 3 years | 0.04 | | 1.2 |
| 5 years | 0.04 | | 1.2 |
| 10 years | 0.04 | | 1.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sam Watson
CEO | Chief Executive Officer | - | 18/05/2023 |
Guy Robertson
DFI | Director of Finance/CFO | 72 | 31/08/2016 |
Jason Hine
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Peng Ho
CHM | Chairman | 67 | 04/12/2012 |
Guy Robertson
BRD | Director/Board Member | 72 | 29/06/2022 |
Sam Watson
BRD | Director/Board Member | - | 18/05/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 14/05/26 | Buy | 5,000,000 | 0.2202% | |||
| 14/05/26 | Exercice | 5,000,000 | 0.2202% | |||
| 22/03/26 | Buy | Chief Executive Officer | 1,800,000 | 0.0804% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.51% | +3.77% | +139.13% | +547.06% | 189M | |
| -0.90% | -2.36% | -1.26% | +14.34% | 48.93B | |
| -0.40% | +1.03% | +418.57% | +527.30% | 45.01B | |
| -1.42% | +2.30% | +42.67% | +22.37% | 44.07B | |
| -1.22% | -2.31% | +4.82% | +77.49% | 40.73B | |
| +0.53% | -1.36% | +16.87% | +46.82% | 33.52B | |
| -0.21% | +9.14% | - | - | 17.77B | |
| -0.35% | -1.56% | +21.42% | +120.75% | 16.5B | |
| -1.68% | -1.43% | +11.86% | +30.95% | 14.67B | |
| -1.65% | -1.03% | +75.93% | +41.12% | 13.77B | |
| Average | -1.09% | +2.87% | +81.11% | +158.69% | 27.52B | |
| Weighted average by Cap. | -0.80% | +0.13% | +89.44% | +129.23% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 29.28M 21.11M 18.16M 17.09M 15.61M 29.2M 1.99B 202M 78.35M 1.02B 79.25M 77.53M 3.29B | 73.91M 53.28M 45.84M 43.13M 39.4M 73.71M 5.03B 510M 198M 2.58B 200M 196M 8.31B |
| Net income | 4.9M 3.53M 3.04M 2.86M 2.61M 4.89M 334M 33.8M 13.12M 171M 13.27M 12.98M 551M | 15.4M 11.1M 9.55M 8.99M 8.21M 15.36M 1.05B 106M 41.2M 538M 41.68M 40.77M 1.73B |
| Net Debt | -6.13M -4.42M -3.8M -3.58M -3.27M -6.12M -417M -42.3M -16.41M -214M -16.6M -16.24M -690M | -4.86M -3.5M -3.01M -2.83M -2.59M -4.84M -330M -33.49M -12.99M -170M -13.14M -12.86M -546M |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/09/26 | A$1.100 | -3.51% | 267,530 |
| 04/09/26 | A$1.140 | +2.70% | 445,226 |
| 03/09/26 | A$1.110 | +0.45% | 346,819 |
| 02/09/26 | A$1.105 | -3.07% | 347,437 |
| 01/09/26 | A$1.140 | +7.55% | 1,289,037 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- BLS Stock
Select your edition
All financial news and data tailored to specific country editions
